Skip to main content
Log in

Improving reproducibility of left ventricular ejection fraction in pediatric oncology patients: less is more

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

Reproducible measurement of left ventricular (LV) systolic function by echocardiography is important to detect cancer therapy-related cardiac dysfunction (CTRCD). We hypothesized that limiting the number of imaging operators and use of a single vendor would improve reproducibility of these measures. A standard operating procedure (SOP) whereby LV measurements were standardized and a cardio-oncology imaging team (5 sonographers, 6 cardiologists) was established. All pediatric oncology patient echocardiograms were acquired on a single vendor platform. In total, 100 consecutive pre-SOP and 100 post-SOP studies were reviewed. LV end-diastolic dimension (LVEDD), posterior wall thickness (PW), shortening fraction (SF), and ejection fraction by Simpson’s biplane (EF) were re-measured by 2 blinded readers, and compared to what was originally reported. Image quality was scored by number of LV segments imaged (grades 1–4). Inter-observer reproducibility pre/post-SOP was assessed with intra-class coefficient (α). Reducing the number of imaging operators improved image quality (Grade ≥ 3: 13% vs. 46%, p < 0.001). Reproducibility of PW and LVEDD marginally improved (PW: 0.78 to 0.82; LVEDD: 0.96 to 0.97), and SF improved significantly (α = 0.65 vs. 0.79, p < 0.001). Pre-SOP reproducibility of LV EF was poor (α = 0.65), but improved significantly post-SOP (α = 0.83, p < 0.001). Reproducibility of LV EF improved with higher image quality score. Limiting imaging operators and vendor platform for pediatric oncology echocardiograms improves image quality and reproducibility of LV EF. Establishing an SOP and a cardio-oncology echocardiography team may improve precision of measurements used to detect CTRCD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

The data from this research is available for review.

References

  1. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF et al (2016) SEER cancer statistics review, 1975–2013. National Cancer Institute, Bethesda

    Google Scholar 

  2. Mertens AC, Liu Q, Neglia JP, Wasilewski K, Leisenring W, Armstrong GT et al (2008) Cause-specific late mortality among 5-year survivors of childhood cancer: the childhood cancer survivor study. J Natl Cancer Inst 100(19):1368–1379

    Article  Google Scholar 

  3. Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M et al (2014) Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 27:911–939

    Article  Google Scholar 

  4. Snipelisky D, Park JY, Lerman A, Mulvagh S, Lin G, Pereira N et al (2017) How to develop a cardio-oncology clinic. Heart Fail Clin 13:347–359

    Article  Google Scholar 

  5. Seraphim A, Westwood M, Bhuva AN, Crake T, Moon JC, Menezes LJ et al (2019) Advanced imaging modalities to monitor for cardiotoxicity. Curr Treat Options Oncol 20:73

    Article  Google Scholar 

  6. Lipshultz SE, Landy DC, Lopez-Mitnik G, Lipsitz SR, Hinkle AS, Constine LS et al (2012) Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy. J Clin Oncol 30:1050–1057

    Article  Google Scholar 

  7. Pein F, Sakiroglu O, Dahan M, Lebidois J, Merlet P, Shamsaldin A et al (2004) Cardiac abnormalities 15 years and more after Adriamycin therapy in 229 childhood survivors of a solid tumor at the Institute Gustave Rousesy. Br J Cancer 91:37–44

    Article  CAS  Google Scholar 

  8. De Souza AM, Potts JE, Potts MT, De Souza ES, Rowland TW, Pritchard SL et al (2007) A stress echocardiography study of cardiac function during progressive exercise in pediatric oncology patients treated with anthryaclines. Pediatr Blood Cancer 49:56–64

    Article  Google Scholar 

  9. Armenian SH, Hudson MM, Mulder RL International Late Effects of Childhood Cancer Guideline Harmonization Group et al (2015) Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol 16(3):e123–e136

    Article  Google Scholar 

  10. Jacobs LD, Salgo IS, Goonewardena S, Weinert L, Coon P, Bardo D et al (2006) Rapid online quantification of left ventricular volume from real-time three-dimensional echocardiographic data. Eur Heart J 27:460–468

    Article  Google Scholar 

  11. Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F et al (2015) Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation 131(22):1981–1988

    Article  CAS  Google Scholar 

  12. Lee CK, Margossian R, Sleeper LA, Canter CE, Chen S, Tani LY et al (2014) Reproducibility of M-Mode versus two-dimensional echocardiography measurements in children with dilated cardiomyopathy. Pediatr Cardiol 35:658–667

    Article  Google Scholar 

  13. Frommelt PC, Minich LL, Trachtenberg FL, Altmann K, Camarda J, Cohen MS et al (2019) Challenges with left ventricular functional parameters: the Pediatric Heart Network normal echocardiogram database. J Am Soc Echocardiogr 32:1331–1338

    Article  Google Scholar 

  14. Lipshultz SE, Lipsitz SR, Sallan SE, Dalton VM, Mone SM, Gelber RD et al (2005) Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23:2629–2636

    Article  CAS  Google Scholar 

  15. Skitch A, Mital S, Mertens L, Liu P, Kantor P, Grosse-Wortmann L et al (2017) Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study. BMC Cancer 17:519

    Article  Google Scholar 

  16. Khouri MG, Ky B, Dunn G, Plappert T, Englefield V, Rabineau D et al (2018) Echocardiography core laboratory reproducibility of cardiac safety assessments in cardio-oncology. J Am Soc Echocardiogr 31:361–371

    Article  Google Scholar 

  17. Johri AM, Picard MH, Newell J, Marshall JE, King ME, Hung J (2011) Can a teaching intervention reduce interobserver reproducibility in LVEF assessment: a quality control exercise in the echocardiography lab? JACC Cardiovasc Imaging 4:821–829

    Article  Google Scholar 

  18. Thavendiranathan P, Popovic ZB, Flamm SD, Dahiya A, Grimm RA, Marwick TH (2013) Improved interobserver reproducibility and accuracy of echocardiographic visual left ventricular ejection fraction assessment through a self-directed learning program using cardiac magnetic resonance imaging. J Am Soc Echocardiogr 26:1267–1273

    Article  Google Scholar 

  19. Daubert MA, Yow E, Barnhart HX, Rabineau D, Crowley AL, Douglas PS (2015) Quality improvement implementation: improving reproducibility in the echocardiography laboratory. J Am Soc Echocardiogr 28:959–968

    Article  Google Scholar 

  20. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for chamber quantification in Adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1–39

    Article  Google Scholar 

  21. Thavendiranathan P, Grant AD, Negishi T, Plana JC, Popović ZB, Marwick TH (2013) Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol 61:77–84

    Article  Google Scholar 

  22. Armstrong GT, Plana JC, Zhang N, Srivastava D, Green DM, Ness KK et al (2012) Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging. J Clin Oncol 30:2876–2884

    Article  Google Scholar 

  23. Mor-Avi V, Lang RM (2013) Is echocardiography reliable for monitoring the adverse cardiac effects of chemotherapy? J Am Coll Cardiol 61:85–87

    Article  Google Scholar 

  24. Bountioukos M, Doorduijn JK, Roelandt JR, Vourvouri EC, Bax JJ, Schinkel AF et al (2003) Repetitive dobutamine stress echocardiography for the prediction of anthracycline cardiotoxicity. Eur J Echocardiogr 4:300–305

    Article  CAS  Google Scholar 

  25. Mele D, Rizzo P, Pollina AV, Fiorencis A, Ferrari R (2015) Cancer therapy-induced cardiotoxicity: role of ultrasound deformation imaging as an aid to early diagnosis. Ultrasound Med Biol 41:627–643

    Article  Google Scholar 

  26. Cheng S, Larson MG, McCabe EL, Osypiuk E, Lehman BT, Stanchev P et al (2013) Reproducibility of speckle-tracking-based strain measures of left ventricular function in a community-based study. J Am Soc Echocardiogr 26(1258–66):e2

    Google Scholar 

  27. Farsalinos KE, Daraban AM, Unlu S, Thomas JD, Badano LP, Voigt JU (2015) Head-to-head comparison of global longitudinal strain measurements among nine different vendors: the EACVI/ASE inter-vendor comparison study. J Am Soc Echocardiogr 28:1171–1181

    Article  Google Scholar 

Download references

Funding

This research was not funded.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. W. Loar.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 11 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Loar, R.W., Pignatelli, R.H., Tunuguntla, H.P. et al. Improving reproducibility of left ventricular ejection fraction in pediatric oncology patients: less is more. Int J Cardiovasc Imaging 36, 1887–1895 (2020). https://doi.org/10.1007/s10554-020-01901-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-020-01901-w

Keywords

Navigation